MODIFICATION TO: REAADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KIT

System, Test, Anticardiolipin Immunological

CORGENIX, INC.

The following data is part of a premarket notification filed by Corgenix, Inc. with the FDA for Modification To: Reaads Anti-phosphatidylserine Igg/igm Semi-quantitative Test Kit.

Pre-market Notification Details

Device IDK012567
510k NumberK012567
Device Name:MODIFICATION TO: REAADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KIT
ClassificationSystem, Test, Anticardiolipin Immunological
Applicant CORGENIX, INC. 12061 TEJON ST. Westminster,  CO  80234
ContactNanci Dexter
CorrespondentNanci Dexter
CORGENIX, INC. 12061 TEJON ST. Westminster,  CO  80234
Product CodeMID  
CFR Regulation Number866.5660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2001-08-09
Decision Date2001-08-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.